[Analysis of clinical and laboratory findings of Pimafucin treated colpitis caused by fungi and mixed infections].
D000935:Antifungal Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008795:Metronidazole / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy*; D010866:Natamycin / Q000008:administration & dosage; D009761:Nystatin / Q000627:therapeutic use; D014247:Trichomonas Vaginitis / Q000188:drug therapy*; D014627:Vaginitis / Q000188:drug therapy*
D000935:Antifungal Agents; D009761:Nystatin; D008795:Metronidazole; D010866:Natamycin
Analyse von klinischen und Laboratoriumserfahrungen an Hand der Pimafucin-Behandlung der Kolpitiden, hervorgerufen durch hefen und Mischinfektion.